Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 415-421, February 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palzer, R. J.
Right arrow Articles by Heidelberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palzer, R. J.
Right arrow Articles by Heidelberger, C.

Studies on the Quantitative Biology of Hyperthermic Killing of HeLa Cells1

Robert J. Palzer and Charles Heidelberger2

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706

The quantitative biology of hyperthermic killing of HeLa cells was studied. Plots of cell survival versus doses of hyperthermia did not show first-order kinetics. The rate of HeLa cell killing shows a striking temperature-dependent relationship in the 41.0–43.0° temperature range. There is a delay of approximately 1 day in the division of cells heated to 42.0°, after which time some cells resume normal growth, whereas others divide at least once before death. Cells selected for their capacity to survive prolonged periods of hyperthermia are killed at approximately the same rate during subsequent heat treatments as cells that had not been heated previously. Hyperthermic cell killing is reduced in cells that are heated in the presence of certain compounds that are inhibitors of DNA and protein synthesis. Fractionated dose experiments indicate that cells recover from sublethal hyperthermic damage. Furthermore, hyperthermic killing is at least a two-step process, and cells are capable of recovery from potentially lethal damage, particularly in the presence of cycloheximide and high levels of thymidine.

1 This work was supported in part by Grants CA-07175 and CRTY-5002 from the National Cancer Institute, NIH.

2 American Cancer Society Professor of Oncology.

Received 9/13/72. Accepted 11/ 8/72.




This article has been cited by other articles:


Home page
ScienceHome page
J. Kim, S. Kim, E. Hahn, and C. Song
5-Thio-D-glucose selectively potentiates hyperthermic killing of hypoxic tumor cells
Science, April 14, 1978; 200(4338): 206 - 207.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.